How is the Nurix Therapeutics Inc today?

The Nurix Therapeutics Inc today is trading in the down by -2.92% at 11.62.

How has Nurix Therapeutics Inc performed historically?

The Nurix Therapeutics Inc is currently trading down -2.92% on an intraday basis in the past week the index rose 2.02%. The index has been down -12.89% in the past quarter and fell -44.75% in the past year. You can view this in the overview section.

What is Nurix Therapeutics Inc Annual Revenue?

Nurix Therapeutics Inc Annual Revenue fell 29.15%, in the last year to $54.55 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Nurix Therapeutics Inc Annual Net Profit?

Nurix Therapeutics Inc Annual Net Profit fell 34.47% in the last year to $193.57 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Nurix Therapeutics Inc Price to Earning Ratio?

Nurix Therapeutics Inc Price to Earning Ratio is -4.25, which is negative.

What is Nurix Therapeutics Inc Stock Price?

Nurix Therapeutics Inc Stock Price fell 44.75% and underperformed its sector by 105.25% in the past year.

What is Nurix Therapeutics Inc Quarterly Revenue?

Nurix Therapeutics Inc Quarterly Revenue rose 11.26% YoY to $18.45 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Nurix Therapeutics Inc Quarterly Net profit?

Nurix Therapeutics Inc Quarterly Net profit fell 35.73% YoY to $56.35 M. Its sector's average net profit growth YoY for the quarter was -236.03%.

What is Nurix Therapeutics Inc Debt to Equity Ratio?

Nurix Therapeutics Inc Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Nurix Therapeutics Inc Return on Equity(ROE)?

Nurix Therapeutics Inc Return on Equity(ROE) for the last financial year was -53.22%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Nurix Therapeutics Inc Mutual Fund Holding?

Nurix Therapeutics Inc Mutual Fund Holding decreased by 2% in the last quarter to 65.04.

What is Nurix Therapeutics Inc Institutional Holding?

Nurix Therapeutics Inc Institutional Holding increased by 5.45% in the last quarter to 112.72.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
NURIX THERAPEUTICS INC

Nurix Therapeutics Inc XNAS: NRIX

Nurix Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Nurix Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Nurix Therapeutics Inc
Rating: 1.186388875
Author: Trendlyne DVM scores

Momentum Trap

about

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disor...

11.62 -0.35 (-2.92%)

60.69% Fall from 52W High

599.5K

XNAS Volume

XNAS 25 Jun, 2025 5:30 PM (EDT)

Low Financial Strength

22.2 / 100

Expensive Valuation

13.7 / 100

Technically Neutral

36.8 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 161%

18 analysts

Nurix Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Nurix Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disor...

60.69% Fall from 52W High

SWOT Analysis

Nurix Therapeutics Inc Live Price Chart

Nurix Therapeutics Inc FAQ

How is Nurix Therapeutics Inc today?

Nurix Therapeutics Inc today is trading in the red, and is down by -2.92% at 11.62.

How has Nurix Therapeutics Inc performed historically?

Nurix Therapeutics Inc is currently trading down -2.92% on an intraday basis. In the past week the stock rose 2.02%. stock has been down -12.89% in the past quarter and fell -44.75% in the past year. You can view this in the overview section.